David L. Rimm, MD, PhD, is a pathologist who specializes in biomarker assessment in lung and breast cancer and has dedicated much of his career to improving how cancers can be diagnosed through better diagnostic tests or through discovering new molecular biomarkers. As a medical student, Dr. Rimm so enjoyed puzzling over the origins and process of diagnosing a patient’s disease that a mentor suggested he consider specializing in pathology. “It always seemed like the most scientific area of medicine, where you have time to perform research to improve diagnostics for patients,” Dr. Rimm says.
His natural inclination toward research pushed Dr. Rimm to sub-specialize in cytopathology, a branch of pathology where diagnoses are based on examining very small samples of patient’s tissue at a cellular level.
Years In Practice
Smilow Cancer Hospital, Yale Medicine